GLIMISAVE MV 2/.2 F (Glimepiride (2mg) + Metformin (1000mg) + Voglibose (0.2mg))

GLIMISAVE MV 2/.2 F is a medication commonly used to help manage blood sugar levels in individuals with type 2 diabetes. It combines three active ingredients—Glimepiride, Metformin, and Voglibose—to work together and support patients in controlling their diabetes. This combination helps reduce blood sugar spikes after meals and improve overall blood sugar regulation.

Glimepiride works by stimulating the pancreas to produce more insulin, which helps lower blood sugar levels. Metformin improves the body’s sensitivity to insulin and decreases the amount of glucose produced by the liver, while Voglibose slows down the absorption of carbohydrates in the intestines, leading to more stable post-meal blood sugar levels.

For optimal effectiveness, store GLIMISAVE MV in a cool, dry place away from direct sunlight. Consistency in taking this medication as advised by a healthcare provider is important for maintaining stable blood sugar levels. It is also essential to regularly monitor blood sugar levels as recommended by your doctor and to adhere to a healthy diet and active lifestyle.

Some common, mild side effects may include nausea, headache, or digestive issues like gas and bloating. These effects often diminish over time but should be discussed with a healthcare professional if they persist.

This is general information, not a substitute for medical advice. Always consult a doctor/pharmacist and read the package leaflet.